Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06659965 · ClinicalTrials.gov registry record
Intravenous Methocarbamol for Acute Pain After Spine Surgery
A clinical trial of Spine Surgery and Multimodal Analgesia, sponsored by The University of Texas Health Science Center, Houston.
- Completed
- Registry status
- 1,270
- Enrollment target
- 1
- Study location
NCT06659965 is a study of Spine Surgery and Multimodal Analgesia that has completed, run by The University of Texas Health Science Center, Houston. The registered enrollment target is 1,270 participants, above the 76-participant average among 6 other Spine Surgery trials with a reported enrollment target (1571% higher). The trial reports 1 study location across 1 state.
The verdict
NCT06659965, a study of Spine Surgery and Multimodal Analgesia, has completed, sponsored by The University of Texas Health Science Center, Houston.
- COMPLETED
- Registry status
- 1,270 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this target trial emulation is to evaluate the impact of intravenous (IV) methocarbamol on postoperative pain and opioid use in adults undergoing elective spine surgery. The main questions it aims to answer are: * Does IV methocarbamol reduce pain in the 6 hours following surgery? * Does IV methocarbamol decrease the need for opioid pain medications in the same period? Participants who receive IV methocarbamol as part of their routine postoperative care will have their pain scores and opioid consumption tracked for 6 hours after treatment. Pain levels will be measured using standard assessments, and opioid use will be quantified in oral morphine equivalents.
Conditions Studied
Interventions
- DRUG Intravenous Methocarbamol
Study Locations (1)
Texas
- Memorial Hermann Health System - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,270 participants |
| Start Date | 2020-01-01 |
| Est. Completion | 2025-06-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06659965
The ClinicalTrials.gov registry entry for NCT06659965 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 1,270 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 76-participant average among 6 other Spine Surgery trials with a reported enrollment target (1571% higher). The listed sponsor is The University of Texas Health Science Center, Houston, which has 732 total studies on file at ClinicalTrials.gov.
The record links to 5 conditions, with Spine Surgery appearing as the primary indexed condition, and to 1 intervention - of which Intravenous Methocarbamol is the first listed.
NCT06659965 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT06659965 about?
NCT06659965 is a clinical study titled "Intravenous Methocarbamol for Acute Pain After Spine Surgery". The goal of this target trial emulation is to evaluate the impact of intravenous (IV) methocarbamol on postoperative pain and opioid use in adults undergoing elective spine surgery. The main questions it aims to answer are: * Does IV methocarbamol reduce pain in the 6 hours following surgery? * Doe...
What is the current status of trial NCT06659965?
This trial is currently completed. The enrollment target is 1,270 participants. The study started on 2020-01-01. Estimated completion is 2025-06-30.
What conditions does trial NCT06659965 study?
This clinical trial studies the following conditions: Spine Surgery, Multimodal Analgesia, Acute Pain, Postoperative, Postsurgical Pain Management, Acute Post Operative Pain.
What interventions are being tested in trial NCT06659965?
The interventions under investigation include: Intravenous Methocarbamol (DRUG).
Who is sponsoring clinical trial NCT06659965?
This trial is sponsored by The University of Texas Health Science Center, Houston, which has 732 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06659965 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Spine Surgery
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Effect of Magnesium on Neuromonitoring
RECRUITING · Phase 4
-
An Open, Parallel-group, Randomized, Medical Device Study to Assess the Usability and Performance of Surgify HaloTM in Spine Surgery Versus State-of-art (Rosen Burr)
RECRUITING · NA
-
Irrisept Solution for Instrumented Spine Surgery
RECRUITING · NA
-
Perioperative Intravenous Lidocaine or Epidural Anesthesia on Outcomes in Complex Spine Surgery
COMPLETED · NA
-
Influence of Dexmedetomidine on the Evoked Potentials During Spine Surgery
COMPLETED · NA
-
Evaluation of Open-Label Conditioned Placebo Analgesia for Postoperative Opioid Reduction Following Spinal Fusion
COMPLETED · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.